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Abstract: 
An oral route of drug administration is the most common and preferred method of delivery due to its convenience 
and ease of ingestion, but for many of drugs it can be hard way due to poor solubility. As the therapeutic activity of 
drugs is related to their solubility in water, in case of poorly water-soluble drugs, dissolution is the rate-limiting 
step in the process of drug absorption hence will lead to low bioavailability. To overcome the problems related with 
oral absorption and bioavailability issue, several strategies have been utilized including hydrotrpes, complexation, 
microcapsulation, use of surfactants, permeation enhancers, micronization, salt formation, Cyclodextrins, 
nanoparticles, solid dispersions, self emulsifying drug delivery system. By the early 1950s the basic physicochemical 
characteristics of cyclodextrins had been discovered and are widely used for the solubilization of poorly soluble 
drugs in the formulations. The versatile pharmaceutical material cyclodextrins (CDs) are classified into hydrophilic, 
hydrophobic, and ionic derivatives. Ibuprofen is a non steroidal anti-inflammatory drug and it is used as an 
analgesic, antipyretic and anti-inflammatory in the treatment of pain. It is very slightly soluble in water (<1 mg/ml, 
BCS class II) and its absorption could be a prerequisite for the quick onset of its action. In the present study 
solubility of ibuprofen was studied in presence of β- cyclodextrin and Hydroxypropyl- β- cyclodextrin at different pH.  
The stability constant (Kc) for ibuprofen in presence of β- cyclodextrin at 7.4, 7.2 and 6.8 were 1368.03, 56.7525 
and 74.2418 respectively. Similarly, stability constant (Kc) in presence of hydroxy propyl-β-cyclodextrin at 7.4, 7.2 
and 6.8 were 790.095, 143.684 and 372.055 respectively. The solubility of ibuprofen in presence of Hydroxypropyl-
β-cyclodextrin was found more than and β- cyclodextrin at pH 7.2. 
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INTRODUCTION: 
Oral route of drug administration is the most 
common and preferred method of delivery due to its 
convenience and ease of ingestion, but for many of 
the drugs it can be hard way due to  poor solubility, 
hence will lead to low bioavailability [1]. Solubility 
is the measure of its saturation to remain undissolved 
while adding solute upon the solvent and it is 
fundamentally depends on the solvent used, 
temperature and pressure [2]. According to the 
Noyes-Whitney equation, solubility of drug 
substance is directly proportional to the dissolution 
rate and hence the therapeutic effectiveness of a drug 
depends upon the dissolution, bioavailability and 
ultimately upon the solubility of drug molecules. 
Thus solubility is one of the influential ways to 
achieve desired concentration of drug in systemic 
circulation. It can be defined in quantitative term, as 
the concentration of solute in a saturated solution at a 
certain temperature and in qualitative terms, as the 
spontaneous interaction of two or more substances to 
form a homogeneous molecular dispersion. [3] 
According to the BCS classification about 8% of new 
drugs have both high solubility and permeability [1]. 
In case of poorly water-soluble drugs, dissolution is 
the rate-limiting step in the process of drug 
absorption. The potential bioavailability problems are 
prevalent/ regnant with extremely hydrophobic drugs 
(aqueous solubility less than 0.1 mg/ml at 37°C), due 
to erratic or incomplete absorption from GIT [4].  
Ibuprofen is a non steroidal anti-inflammatory drug 
and it is used as an analgesic, antipyretic and anti-
inflammatory in the treatment of pain [5] and 
chemically is 2-(4 isobutyl phenyl) propionic acid. 
The empirical formula for Ibuprofen is C13H18O2 and 
its molecular weight is 206.29 g/mol [6].   It is white 
powder that is very slightly soluble in water (<1 
mg/ml) and readily soluble in organic solvent such as 
ethanol and acetone [7]. Ibuprofen is a BCS class II 
drug; its absorption could be a prerequisite for the 
quick onset of its action [8]. Its oral bioavailability is 
about 87-100%, with a mean peak plasma 
concentration of 25-35μg/ml at about 2 hours after of 
one 400 mg oral dose [9]. It is extensively bound to 
plasma proteins (99%), and has a relatively short 
elimination half - life (2-4 hrs). Ibuprofen has pKa of 
4.7-4.8 [10]. Enhancing solubility and dissolution 
rate of poorly water-soluble drug is one of the 
striking areas of research in pharmaceutical field 
[11].  
To overcome the problems related with oral 
absorption and bioavailability issue, several 
approaches have been utilized including hydrotrpes 
[3] , complexation [12] , microcapsulation  [13], use 
of surfactants, permeation enhancers, micronization, 
salt formation, cyclodextrins, nanoparticles, solid  
 
dispersions, self emulsifying drug delivery system  
etc [14,15].  
The therapeutic activity of drugs is related to their 
solubility in water [16].In the case of poorly water-
soluble drugs, dissolution is the rate-limiting step in 
the process of drug absorption.[17] Cyclodextrins are 
widely used for the solubilization of poorly soluble 
drugs in the formulations. [18]The versatile 
pharmaceutical material cyclodextrins (CDs) are 
classified into hydrophilic, hydrophobic, and ionic 
derivatives. By the early 1950s the basic 
physicochemical characteristics of cyclodextrins had 
been discovered, since than their use is a practical 
and economical way to improve the physicochemical 
and pharmaceutical properties such as solubility, 
stability, and bioavailability of administered drug 
molecules.[19] Sudipta Das and et al, prepared 
complexes of ibuprofen with cyclodextrin in molar 
ratio by co-precipitation method and inclusion 
complexes were further formulated into tables by 
direct compression technique using 
superdisintegrants in order to increase the solubility 
of ibuprofen for improvement of dissolution rate and 
bioavailability. [20] Stiliyana P and et al used 
modified method for ibuprofen and β-cyclodextrin 
complex formation. Modified method based on ball 
milling under controlled conditions was developed 
and its efficiency with respect to the drug 
encapsulation yield was compared with the kneading 
and solid dispersion methods for inclusion 
complexes. [21]   Qifang W and et al were prepared 
solid state of the co-ground complex to investigate 
the possibility of improving the dissolution and 
stabilization of Ibuprofen, a poorly water-soluble 
drug, by grinding in a high energy mill with β-
cyclodextrin (β-CD). The dissolution rate of solid 
state of the co-ground complex was determined 
according to the dispersed amount method.[22] Iwata 
M and et al  investigated the enhancement of the 
solubility of glimepiride (GLM), a poorly water 
soluble antidiabetes drug, by cogrinding it with 
various cyclodextrins (CDs) using a ball mill. The 
phase solubility profiles of glimepiride with β-CD 
and its derivatives were classified as AL-type, 
indicating the formation of a 1:1 stoichiometric 
water-soluble complex. When GLM crystals were 
cogrounded with β-CD using a ball mill for 48 h, the 
aqueous solubility of GLM increased to 
approximately 250 mg/ml. [23]       
The present research work aimed to study the 
solubility of ibuprofen at different pH in presence of 
β- cyclodextrin and hydroxypropyl- β- cyclodextrin 
and hence to make improvement  in dissolution rate 
and bioavailability. 
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MATERIALS AND METHODS: 
Materials 
Ibuprofen was obtained as gift sample from the 
Unicure Remedies Pvt. Ltd. Vadodara (Gujarat, 
India). Β-cyclodextrin (β-CD) and Hydroxypropyl- β-
cyclodextrin (HP-β-CD) were purchased from 
Yarrow Chem. Products Mumbai.  All other 
ingredients used were of analytical grade. 
Method 
Preparation of Calibration curve of Ibuprofen 
Accurately weighed Ibuprofen (100mg) was and 
transferred to 100 ml volumetric flask and dissolved 
in phosphate buffer solution (pH 6.8, 7.2 or 7.4).  The 
final volume was adjusted up to 100 ml with the 
respective phosphate buffer solution to get first stock 
solution (FSS). One milliliter of  FSS  (1000 mcg/ml) 
was transferred to another volumetric flask and 
diluted with respective buffer solution up to 100 ml 
to get second stock solution (SSS). Further, 1 ml,2 
ml,3 ml,4 ml,…..9  ml of  second stock solution 
diluted up to 10 ml to get the solutions corresponding 
to 1 μg/ml, 2 μg/ml,3 μg/ml,4 μg/ml …..9 μg/ml and 
the absorbance were recorded at 221 nm by 
spectrophotometrically using respective buffer 
solution as blank (Shimadzu Double Beam 
Spectrophotometer-Model- UV 1700). The 
calibration curve was plotted using absorbance verses 
concentration and regression coefficient was 
calculated from the straight line equation. [24-26] 
Phase solubility studies 
Phase solubility studies were carried according to the 
method reported by Higuchi and Connors [27]. An 
excess amount of drug (Ibuprofen, 200mg) was 
added to glass containers (10 ml), containing ß-
cyclodextrin (β-CD) and hydroxypropyl- ß-
cyclodextrin (HP-β-CD) in buffer media of different 
pH like 6.8, 7.2, 7.4. The concentration of ß-
cyclodextrin (β-CD) and hydroxypropyl- ß-
cyclodextrin (HP-β-CD) in solution were ranging 
from 0 to 0.01 mol. The glass containers were sealed 
and rotated for 48 hrs at 30 rpm. After 48 hours, 
sample solutions were filtered suitably diluted and 
ibuprofen content was determined by UV method at 
221 mm.  
The phase solubility diagram was constructed by 
plotting the dissolved ibuprofen against respective 
concentration of ß-CD. The binding constant Ka was 
calculated from phase solubility diagram using its 
slope and intercept values using equation  
Kc=Slope/So(1-Slope)                                     
Where, Ka is apparent stability constant,  So is 
solubility of drug without cyclodextrin, M is molar 
concentration  22,24. 
The solubility data of ibuprofen in presence of β-CD 
and HP-β-CD was analyzed statistically (Student t 
test) to evaluate the effect of host (β-CD and HP-β-
CD) and pH of the media.  
 
RESULT AND DISCUSSION: 
Calibration curve of Ibuprofen 
The calibration curve of ibuprofen in different buffers 
was prepared by measuring the absorbance in 
phosphate buffers pH 6.8, pH 7.2, and pH 7.4 and 
showed the linearity over the concentration range of 
1 - 10 μg/ml, which follows the Beer and Lamberts 
law. The absorbance of the solutions measured at the 
wavelength 221.0 nm. The results of standard curve 
are shown in Table and Figure. The regression 
coefficients (R2) for straight line were found to be   
0.998, 0.980 and 0.996 for phosphate buffers pH 6.8, 
pH 7.2, and pH 7.4 respectively.   
 
 
Table 1: Absorbance of Ibuprofen at 221 nm in phosphate buffer  
Sr. 
No. 
Concentration of 
Ibuprofen (mcg/ml) 
Absorbance at 221 nm 
pH 6.8 pH 7.2 pH 7.4 
1 0 0 0 0 
2 1 0.063 0.038 0.064 
3 2 0.104 0.085 0.103 
4 3 0.134 0.121 0.144 
5 4 0.178 0.105 0.182 
6 5 0.222 0.200 0.229 
7 6 0.269 0.255 0.29 
8 7 0.308 0.295 0.318 
9 8 0.342 0.332 0.366 
10 9 0.386 0.358 0.404 
11 10 0.433 0.430 0.473 
Regression coefficient 0.998 0.980 0.996 
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Fig 1: Calibration Curve of Ibuprofen in Phosphate buffer solutions 
 
 
Phase solubility study  
The solubility of ibuprofen in phosphate buffers pH 
6.8, pH 7.2 and pH 7.4 were studied in presence of β-
CD and HP-β-CD.  The phase solubility diagrams 
were obtained by plotting the graph amount of 
ibuprofen solubilized verses concentration of 
respective cyclodextrin. The apparent stability 
constant (Kc) and complexation efficiency (CE) was 
calculated from the linear plot of the phase solubility 
diagram and according to the equation... 
 (1) 
 (2) 
Where, So = solubility of the drug in absence of β-CD 
and HP-β-CD. 
The results of solubility of ibuprofen in phosphate 
buffers pH 7.4, pH 7.2 and pH 6.8 in presence of β-CD 
are shown in table 2 and 3 and figure 2 and 3. The 
result showed that, maximum solubility of ibuprofen 
in presence of β-CD and HP-β-CD was found to be 
0.00429 mcg/ml and 0.00518 mcg/ml respectively at 
pH 7.2. In all pH range, the aqueous solubility was 
increased linearly with β-CD and HP-β-CD 
concentration. All phase solubility diagrams are 
classified as type AL according to Higuchi and 
Connors. The slope values were found to be less than 
unity in each case indicating the formation of 1:1 
stoichiometric complexes 
 
Table No 2: Solubility study of ibuprofen in different pH with β-CD 
Sr.  No. β-cyclodextrin concentration 
(Mol) 
Solubility of Ibuprofen 
(mg/ml) in different  pH 
pH 6.8 pH 7.2 pH 7.4 
1 0 0.00148 0.00275 0.000433 
2 0.001 0.00156 0.00265 0.00026 
3 0.002 0.00174 0.00303 0.00044 
4 0.003 0.0019 0.00316 0.00073 
5 0.004 0.002 0.00326 0.00112 
6 0.005 0.00202 0.00328 0.00153 
7 0.006 0.00215 0.00335 0.00176 
8 0.007 0.00226 0.00341 0.00265 
9 0.008 0.00231 0.00363 0.00276 
10 0.009 0.0024 0.00386 0.00325 
11 0.01 0.00249 0.00429 0.00323 
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Fig 2: Phase solubility studies of ibuprofen with β-CD 
 
 
Table 3: Solubility study of ibuprofen in different pH with HP-β-CD 
 
Sr. No. Hydroxy propyl β-
Cyclodextrin 
concentration(M) 
Solubility of Ibuprofen 
(mg/ml) in different  pH 
pH 6.8 pH 7.2 pH 7.4 
1 0 0.00059 0.00272 0.000522 
2 0.001 0.000597 0.00259 0.000542 
3 0.002 0.00069 0.00284 0.000737 
4 0.003 0.00076 0.00304 0.001044 
5 0.004 0.00098 0.00331 0.001306 
6 0.005 0.00135 0.00357 0.001564 
7 0.006 0.001356 0.00384 0.001946 
8 0.007 0.00149 0.0045 0.00222 
9 0.008 0.00183 0.00471 0.00265 
10 0.009 0.00202 0.005 0.00298 
11 0.01 0.00238 0.00518 0.003266 
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Fig 3: Phase solubility studies of ibuprofen with HP-β-CD 
Table 4:  Solubility study of Ibuprofen in different pH 
Sr. 
No. 
pH of 
media 
Solubility of Ibuprofen in different 
pH with β-Cyclodextrin 
Solubility of Ibuprofen in different pH 
with  HP- β-Cyclodextrin 
KC CE KC CE 
1 7.4 1368.03 0.59236 790.095 0.41243 
2 7.2 56.7525 0.15607 143.684 0.39082 
3 6.8 74.2418 0.10988 372.055 0.21951 
 
Kc values in the range of 100-1000M-1 indicated 
stronger interactions between the guest molecules 
(drug) and host molecules (β-CD and HP-β-CD) and 
greater stability of the complex formed. [28]The 
value of stability constants complexes formed 
between drug-β-CD and drug-HP-β-CD are quite 
stable in all cases. 
The solubility of drug increases with increase in host 
concentration and phase solubility study showed AL 
type of graph using β-CD and HP-β-CD (0.001 to 
0.1M) in pH 6.8, pH 7.2 and pH 7.4, buffer media. The 
apparent stability constant values of inclusion 
complexes at pH 7.2 in presence of β-CD and HP-β-
CD were found to 56.7525 M-1 and 143.684 M-1 
respectively. 
 The solubility data of ibuprofen in presence of β-CD 
and HP-β-CD was analyzed statistically to evaluate 
the effect of host (β-CD and HP-β-CD) and pH of the 
media. The solubility of ibuprofen was found to be 
greater in presence of HP-β-CD s than β-CD. (P 
values for pH 6.8, 7.2 and 7.4 were 1.388 x 10-5, 0.02 
and 0.457 respectively). It showed that there has been 
remarkable increase in solubility at pH 6.8 and 7.2, 
but no significant increase at pH 7.4. The maximum 
solubility of Ibuprofen was found maximum in pH 7.2 
buffer media with HP-β-CD as well as β-CD. 
 
CONCLUSION:  
The aqueous solubility of ibuprofen can increase by 
the inclusion complexation with β- cyclodextrin and 
hydroxypropyl β-cyclodextrin. The complexes 
formed were stable and maximum solubility of 
ibuprofen was found maximum in pH 7.2 buffer 
media in presence of hydroxypropyl β-Cyclodextrin.  
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